Steven Favaloro, incoming Genezen CEO (L) and Mark Womack, incoming BioCina CEO
March 16, 2023 11:33 AM EDT
People
Manufacturing

Con­tract man­u­fac­tur­ers BioCi­na and Genezen name new CEOs

Tyler Patchen

News Reporter

A pair of CD­MOs are bring­ing in new CEOs.

Tak­ing the helm at BioCi­na is Mark Wom­ack. Ac­cord­ing to his LinkedIn

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

Met­sera rais­es $215M for stud­ies of GLP-1 and amylin obe­si­ty drugs

Adap­ti­m­mune's sec­ond T cell re­cep­tor cell ther­a­py for rare sar­co­mas pass­es piv­otal test

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

J&J takes 340B fight with fed­er­al gov­ern­ment to court

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times